Public Health - Medetomidine and Xylazine Consumer Protection Act
Prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine product or xylazine product unless the purchaser provides proof the intended use is for institutional, veterinary, or scientific purposes; prohibiting a retailer from distributing, selling, or exposing for sale a medetomidine or xylazine product to an individual under the age of 21 years; requiring a retailer that prepares, distributes, sells, or exposes for sale a medetomidine or xylazine product to maintain certain records; etc.
Where it stands
Last action: Motion Laid Over (Senator Ready) Adopted · Apr 13, 2026
Community sentiment
No ratings yet — be the first.
Verified
0 ratings
Unverified
0 ratings
Your rating
Sign in to rate this bill on all four criteria.
Support map (approximate)
No locations yet.
Dots are approximate. Verified voters appear as brass dots near their address (jittered so points are county-level, never exact). Unverified dots are taken from rough IP location at vote time.
No verified locations yet — verify your vote to put your county on the map.
Community suggestions
Moderated — approved posts onlyNo approved suggestions yet.
Sign in to suggest a change to this bill. Suggestions are moderated before they appear publicly.